Clinical trials: COVID-19 Mortality
COVID-19, Respiratory Failure
Characteristics and Outcomes of Patients With COVID-19 Treated With HFNO and Prone Positioning
A subset of patients with COVID-19 develops acute respiratory failure and acute respiratory distress syndrome (ARDS) (1). The use of invasive mechanical ventilation for the treatment of these conditions is associated with high…
- Conditions
- COVID-19, Respiratory Failure, Prone Position, Endotracheal Intubation
- Trial name
- AW-PP_Covid (NCT05178212)
- Where
- Argentina
- Volunteers
- 600 people
- Sponsor
- Hospital Privado de Comunidad de Mar del Plata
COVID-19
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
The goal of this project is to rapidly screen promising agents, in the setting of an adaptive platform trial, for treatment of critically ill COVID-19 patients.
- Trial name
- I-SPY_COVID (NCT04488081)
- Testing
- Remdesivir, Imatinib Mesylate, Dexamethasone
- Where
- 36 sites in United States
- Volunteers
- 1,500 people
- Sponsor
- QuantumLeap Healthcare Collaborative
SARS-CoV 2
Muscle Mass and Strength as Predictors of Time to Discharge in Patients With COVID-19
The severe acute respiratory syndrome induced by the new coronavirus (SARS-CoV-2) has been declared a worldwide pandemic. Identifying common characteristics of the disease is crucial to promote a better prognosis for patients and…
- Trial name
- NCT04406233
- Where
- Brazil
- Volunteers
- 176 people
- Sponsor
- University of Sao Paulo
COVID-19, COVID-19 Pneumonia
Effect of Covid 19 Infection on Fetomaternal Outcome
The novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was discovered for the first time in December 2019 in Wuhan (China) and the disease it causes is called coronavirus disease 2019…
- Conditions
- COVID-19, COVID-19 Pneumonia, Fetal Growth Retardation
- Trial name
- NCT05160649
- Where
- Egypt
- Volunteers
- 50 people
- Sponsor
- Fayoum University
Covid19, Thromboembolism
Is Anti-Factor Xa Associated With Outcome in Patients With Critical COVID-19 on Low-Molecular-Weight Heparin?
Patients with critical COVID-19 are hyper-coagulable and optimal thromboprophylaxis treatment differs with stage and severity. The most commonly used drug for thromboprophylaxis in the intensive care unit (ICU) is…
- Conditions
- Covid19, Thromboembolism, Bleeding
- Trial name
- AntiXCOVID (NCT05256524)
- Testing
- The effect of LMWH, Monitoring frequency of aFXa-levels
- Where
- Sweden
- Volunteers
- 1,520 people
- Sponsor
- Karolinska Institutet
COVID-19, SARS-CoV-2
Molnupiravir and COVID-19 Mortality Reduction in the Omicron Era
This retrospective real-world target trial emulation uses complete Czech nationwide registry data to evaluate whether molnupiravir treatment is associated with lower COVID-19 mortality during the Omicron era.
- Trial name
- MOLCOVred (NCT07720596)
- Testing
- Molnupiravir
- Where
- Czechia
- Volunteers
- 1,795,570 people
- Sponsor
- Charles University, Czech Republic
Covid19
COVID-19 Patients Admitted to the ICU
A retrospective analysis of the adult COVID-19 patients admitted to the ICU. A chart review will be conducted and multiple baseline characteristics, demographics, and treatments given will be recorded.
- Trial name
- NCT04816786
- Testing
- no intervention will be administered, this is a retrospective observational study.
- Where
- Kuwait
- Volunteers
- 100 people
- Sponsor
- Ministry of Health, Kuwait
Zinc Deficiency, Sars-CoV-2 Infection
Zinc Supplementation Impact in Acute COVID-19 Clinical Outcomes
Infections with SARS-CoV-2 result in a systemic disease with a variety of outcomes, from no symptoms to severe and diverse pathologies.
- Trial name
- MARZINC (NCT05778383)
- Testing
- Zinc Acetate
- Where
- Spain
- Volunteers
- 75 people
- Sponsor
- Parc de Salut Mar
COVID-19, Respiratory Illness
Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention
The number of cases of COVID-19 is still increasing and transmission of SARS-CoV-2 seems to occur mainly through person-to-person transmission through respiratory droplets, indirect contact with infected people and surfaces.
- Trial name
- NCT04471766
- Testing
- Certified cloth face mask plus preventive information, Preventive information
- Where
- Guinea-Bissau
- Volunteers
- 40,000 people
- Sponsor
- Bandim Health Project